Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Device Recall Authority

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0793]

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Device Recall Authority

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

DATES:

Fax written comments on the collection of information by July 13, 2015.

ADDRESSES:

To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-7285, or emailed to

oira_submission@omb.eop.gov.

All comments should be identified with the OMB control number 0910-0432. Also include the FDA docket number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT:

FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver Spring, MD 20993-0002,

PRAStaff@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.

Medical Device Recall Authority—21 CFR 810 (OMB Control Number 0910-0432)—Extension

This collection of information implements section 518(e) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 360h(e)) and part 810 (21 CFR part 810), medical device recall authority provisions. Section 518(e) of the FD&C Act provides FDA with the authority to issue an order requiring an appropriate person, including manufacturers, importers, distributors, and retailers of a device, if FDA finds that there is reasonable probability that the device intended for human use would cause serious adverse health consequences or death, to: (1) Immediately cease distribution of such device; (2) immediately notify health professionals and device-user facilities of the order; and (3) instruct such professionals and facilities to cease use of such device.

Further, the provisions under section 518(e) of the FD&C Act set out the following three-step procedure for issuance of a mandatory device recall order:

• If there is a reasonable probability that a device intended for human use would cause serious, adverse health consequences or death, FDA may issue a cease distribution and notification order requiring the appropriate person to immediately:

○ Cease distribution of the device,

○ notify health professionals and device user facilities of the order, and

○ instruct those professionals and facilities to cease use of the device;

• FDA will provide the person named in the cease distribution and notification order with the opportunity for an informal hearing on whether the order should be modified, vacated, or amended to require a mandatory recall of the device; and

• After providing the opportunity for an informal hearing, FDA may issue a mandatory recall order if the Agency determines that such an order is necessary.

The information collected under the recall authority provisions will be used by FDA to do the following: (1) Ensure that all devices entering the market are safe and effective; (2) accurately and immediately detect serious problems with medical devices; and (3) remove dangerous and defective devices from the market.

In the

Federal Register

of March 11, 2015 (80 FR 13586), FDA published a 60-day notice requesting public comment on the proposed collection of information. No comments were received.

FDA estimates the burden of this collection of information as follows:

Table 1—Estimated Annual Reporting Burden

1

Collection activity—21 CFR Section

Number of

respondents

Number of

responses per

respondent

Total annual responses

Average

burden per

response

Total hours

Collections Specified in the Order—810.10(d)

2

1

2

8

16

Request for Regulatory Hearing—810.11(a)

1

1

1

8

8

Written Request for Review—810.12(a-b)

1

1

1

8

8

Mandatory Recall Strategy—810.14

2

1

2

16

32

Periodic Status Reports—810.16(a-b)

2

12

24

40

960

Termination Request—810.17(a)

2

1

2

8

16

Total Hours

1,040

1

There are no capital costs or operating and maintenance costs associated with this collection of information.

Table 2—Estimated Annual Recordkeeping Burden

1

Collection activity—21 CFR Section

Number of recordkeepers

Number of records per recordkeeper

Total annual records

Average

burden per

recordkeeping

Total hours

Documentation of Notifications to Recipients—810.15(b)

2

1

1

8

8

1

There are no capital costs or operating and maintenance costs associated with this collection of information.

Table 3—Estimated Annual Third-Party Disclosure Burden

1

Collection Activity—21 CFR Section

Number of

respondents

Number of

disclosures

per respondent

Total annual disclosures

Average

burden per

disclosure

Total hours

Notification to Recipients—810.15(a)-(c)

2

1

2

12

24

Notification to Recipients; Followup—810.15(d)

2

1

2

4

8

Notification of Consignees by Recipients—810.15(e)

10

1

10

1

10

Total

42

1

There are no capital costs or operating and maintenance costs associated with this collection of information.

Dated: June 8, 2015.

Leslie Kux,

Associate Commissioner for Policy.

[FR Doc. 2015-14359 Filed 6-11-15; 8:45 am]

BILLING CODE 4164-01-P